Innovations in care and research
The Ohio State University Division of Endocrinology, Diabetes and Metabolism has again been recognized for excellence by U.S. News & World Report. We are committed to excellence in clinical care, the education of medical students, residents and fellows, and to new discoveries to improve the care of patients with endocrine and endocrine-related disorders through laboratory and clinical research. Our division has a long history of outstanding performance in all of these areas and has recognized programs in diabetes, thyroid cancer and other thyroid disorders, adrenal and pituitary disorders and metabolic bone disease.
Our board-certified endocrinologists provide clinical care for patients with all forms of endocrine diseases. Our experts in endocrinology accept referrals throughout the region as well as from around the country.
Featured Stories
Ohio State expert recognized for expanding knowledge of aggressive thyroid cancer
Innovation in inpatient diabetes care preserves resources, reduces exposure to COVID-19
How one Ohio State endocrinologist is translating data into health improvement
Fueling failing hearts– Researchers focus on fat metabolism and heart function
Studying “brake failure” in thyroid cancer metastasis
$5 million NIH award to support Ohio State research addressing COVID-19 testing disparities among vulnerable populations
Ohio State’s premier pituitary program shaped by clinician collaboration, clinical trials
Ohio State endocrinologists studying links between obesity and insulin resistance, fatty liver
Ohio State aims to reduce maternal and fetal health risks among pregnant women with type 1 diabetes
Ohio State researchers launch four new studies on diabetes prevention and treatment
Ohio State leads the way in managing hypoparathyroidism and secondary fracture prevention
Ohio State physicians and scientists continue to break new ground in thyroid cancer care
Leading the way